{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T04:10:31Z","timestamp":1793333431244,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,18]],"date-time":"2021-10-18T00:00:00Z","timestamp":1634515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,18]],"date-time":"2021-10-18T00:00:00Z","timestamp":1634515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. NSF 81601074"],"award-info":[{"award-number":["No. NSF 81601074"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Program Innovative Research Team in Science and Technology in Yunnan Province","award":["No.2017HC007"],"award-info":[{"award-number":["No.2017HC007"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin Med"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Neonatal hypoxic-ischemic encephalopathy (HIE) refers to the perinatal asphyxia caused by the cerebral hypoxic-ischemic injury. The current study was aimed at investigating the therapeutic efficacy of Scutellarin (Scu) administration on neurological impairments induced by hypoxic-ischemic injury and exploring the underlying mechanisms.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Primary cortical neurons were cultured and subjected to oxygen\u2013glucose deprivation (OGD), and then treated with Scu administration. The growth status of neurons was observed by immunofluorescence staining of TUJ1 and TUNEL. Besides, the mRNA level of growth-associated protein 43\u00a0(GAP43) in OGD neurons with Scu treatment was detected by quantitative real-time polymerase chain reaction (qRT-PCR). To further verify the role of GAP43 in Scu treatment, GAP43 siRNA and knockout were applied in vitro and in vivo. Moreover, behavioral evaluations were performed to elucidate the function of GAP43 in the Scu-ameliorated long-term neurological impairments caused by HI insult. The underlying biological mechanism of Scu treatment was further elucidated via network pharmacological analysis. Finally, the interactive genes with GAP43 were identified by Gene MANIA and further validated by qRT-PCR.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Our data demonstrated that Scu treatment increased the number of neurons and axon growth, and suppressed cell apoptosis in vitro. And the expression of GAP43 was downregulated after OGD, but reversed by Scu administration. Besides, GAP43 silencing aggravated the Scu-ameliorated neuronal death and axonal damage. Meanwhile, GAP43 knockout enlarged brain infarct area and deteriorated the cognitive and motor dysfunctions of HI rats. Further, network pharmacological analysis revealed the drug targets of Scu participated in such biological processes as neuronal death and regulation of neuronal death, and apoptosis-related pathways. GAP43 exhibited close relationship with PTN, JAK2 and STAT3, and GAP43 silencing upregulated the levels of PTN, JAK2 and STAT3.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Collectively, our findings revealed Scu treatment attenuated long-term neurological impairments after HI by suppressing neuronal death and enhancing neurite elongation through GAP43-dependent pathway. The crucial role of Scutellarin in neuroprotection provided a novel possible therapeutic agent for the treatment of neonatal HIE.<\/jats:p><\/jats:sec><jats:sec><jats:title>Graphic abstract<\/jats:title><\/jats:sec>","DOI":"10.1186\/s13020-021-00517-z","type":"journal-article","created":{"date-parts":[[2021,10,18]],"date-time":"2021-10-18T22:54:38Z","timestamp":1634597678000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Scutellarin ameliorates neonatal hypoxic-ischemic encephalopathy associated with GAP43-dependent signaling pathway"],"prefix":"10.1186","volume":"16","author":[{"given":"Rui-Ze","family":"Niu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu-Lin","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-Li","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu-Lu","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Jie","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Hua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5678-7437","authenticated-orcid":false,"given":"Jia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,18]]},"reference":[{"issue":"1","key":"517_CR1","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/S0022-3476(81)80555-0","volume":"98","author":"NN Finer","year":"1981","unstructured":"Finer NN, et al. Hypoxic-ischemic encephalopathy in term neonates: perinatal factors and outcome. J Pediatr. 1981;98(1):112\u20137.","journal-title":"J Pediatr"},{"issue":"6","key":"517_CR2","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1542\/peds.100.6.1004","volume":"100","author":"RC Vannucci","year":"1997","unstructured":"Vannucci RC, Perlman JM. Interventions for perinatal hypoxic-ischemic encephalopathy. Pediatrics. 1997;100(6):1004\u201314.","journal-title":"Pediatrics"},{"key":"517_CR3","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1210\/en.2018-00148","volume":"159","author":"Y Kawarai","year":"2018","unstructured":"Kawarai Y, et al. Progesterone as a postnatal prophylactic agent for encephalopathy caused by prenatal hypoxic ischemic insult. Endocrinology. 2018;159:2264\u201374.","journal-title":"Endocrinology"},{"issue":"2","key":"517_CR4","first-page":"205","volume":"71","author":"R Guillet","year":"2012","unstructured":"Guillet R, Edwards A, Thoresen M. Seven-to eight -vear follow-up of the coolcap trial of head cooling forneonatal encephalopathy. Pediatric. 2012;71(2):205\u20139.","journal-title":"Pediatric"},{"issue":"4","key":"517_CR5","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1203\/01.PDR.0000054685.87405.59","volume":"53","author":"T Ogihara","year":"2003","unstructured":"Ogihara T, et al. Non-protein-bound transition metals and hydroxyl radical generation in cerebrospinal fluid of newborn infants with hypoxic ischemic encephalopathy. Pediatr Res. 2003;53(4):594\u20139.","journal-title":"Pediatr Res"},{"issue":"6","key":"517_CR6","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1111\/epi.13745","volume":"58","author":"MP Fitzgerald","year":"2017","unstructured":"Fitzgerald MP, Kessler SK, Abend NS. Early discontinuation of antiseizure medications in neonates with hypoxic\u2013ischemic encephalopathy. Epilepsia. 2017;58(6):1047\u201353.","journal-title":"Epilepsia"},{"issue":"147","key":"517_CR7","first-page":"1","volume":"5","author":"GS Gonzalesportillo","year":"2014","unstructured":"Gonzalesportillo GS, et al. Stem cell therapy for neonatal hypoxic-ischemic encephalopathy. Front Neurol. 2014;5(147):1\u201310.","journal-title":"Front Neurol"},{"issue":"7","key":"517_CR8","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1002\/phar.1263","volume":"33","author":"F Adam","year":"2013","unstructured":"Adam F, et al. Gentamicin pharmacokinetics and dosing in neonates with hypoxic ischemic encephalopathy receiving hypothermia. Pharmacotherapy. 2013;33(7):718\u201326.","journal-title":"Pharmacotherapy"},{"issue":"3","key":"517_CR9","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1097\/FJC.0b013e3180cbd0e7","volume":"50","author":"L Lin","year":"2007","unstructured":"Lin L, et al. Protective effects of scutellarin and breviscapine on brain and heart ischemia in rats. J Cardiovasc Pharmacol. 2007;50(3):327\u201332.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"11","key":"517_CR10","first-page":"1113","volume":"24","author":"H Liu","year":"2003","unstructured":"Liu H, et al. Protective effects of scutellarin on superoxide-induced oxidative stress in rat cortical synaptosomes. Acta Pharmacol Si. 2003;24(11):1113\u20137.","journal-title":"Acta Pharmacol Si"},{"key":"517_CR11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.pbb.2014.01.003","volume":"118","author":"H Tang","year":"2014","unstructured":"Tang H, et al. Neuroprotective effects of scutellarin and scutellarein on repeatedly cerebral ischemia-reperfusion in rats. Pharmacol Biochem Behav. 2014;118:51\u20139.","journal-title":"Pharmacol Biochem Behav"},{"issue":"3","key":"517_CR12","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1111\/j.1476-5381.2010.01070.x","volume":"162","author":"Z Pan","year":"2011","unstructured":"Pan Z, et al. Scutellarin alleviates interstitial fibrosis and cardiac dysfunction of infarct rats by inhibiting TGF\u03b21 expression and activation of p38-MAPK and ERK1\/2. Br J Pharmacol. 2011;162(3):688\u2013700.","journal-title":"Br J Pharmacol"},{"issue":"84","key":"517_CR13","first-page":"1","volume":"16","author":"M Fang","year":"2015","unstructured":"Fang M, et al. Scutellarin regulates microglia-mediated TNC1 astrocytic reaction and astrogliosis in cerebral ischemia in the adult rats. BMC Neurosci. 2015;16(84):1\u201320.","journal-title":"BMC Neurosci"},{"issue":"6","key":"517_CR14","first-page":"399","volume":"54","author":"H Guo","year":"2011","unstructured":"Guo H, et al. Neuroprotective effects of scutellarin against hypoxic-ischemic-induced cerebral injury via augmentation of antioxidant defense capacity. Chin J Physiol. 2011;54(6):399\u2013405.","journal-title":"Chin J Physiol"},{"issue":"2","key":"517_CR15","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1055\/s-0028-1088368","volume":"75","author":"HF Zhang","year":"2009","unstructured":"Zhang HF, et al. Protective effects of scutellarin against cerebral ischemia in rats: evidence for inhibition of the apoptosis-inducing factor pathway. Planta Med. 2009;75(2):121\u20136.","journal-title":"Planta Med"},{"issue":"3","key":"517_CR16","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1523\/JNEUROSCI.10-03-00926.1990","volume":"10","author":"VM Verge","year":"1990","unstructured":"Verge VM, et al. Correlation between GAP43 and nerve growth factor receptors in rat sensory neurons. J Neurosci. 1990;10(3):926\u201334.","journal-title":"J Neurosci"},{"issue":"10","key":"517_CR17","doi-asserted-by":"publisher","first-page":"3537","DOI":"10.1073\/pnas.83.10.3537","volume":"83","author":"KF Meiri","year":"1986","unstructured":"Meiri KF, Pfenninger KH, Willard MB. Growth-associated protein, GAP-43, a polypeptide that is induced when neurons extend axons, is a component of growth cones and corresponds to pp46, a major polypeptide of a subcellular fraction enriched in growth cones. Proc Natl Acad Sci USA. 1986;83(10):3537\u201341.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"517_CR18","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/S0166-2236(96)10072-2","volume":"20","author":"LI Benowitz","year":"1997","unstructured":"Benowitz LI, Routtenberg A. GAP-43: an intrinsic determinant of neuronal development and plasticity. Trends Neurosci. 1997;20(2):84\u201391.","journal-title":"Trends Neurosci"},{"issue":"7351","key":"517_CR19","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature10163","volume":"474","author":"WC Skarnes","year":"2011","unstructured":"Skarnes WC, et al. A conditional knockout resource for the genome-wide study of mouse gene function. Nature. 2011;474(7351):337\u201342.","journal-title":"Nature"},{"issue":"11","key":"517_CR20","doi-asserted-by":"publisher","first-page":"3974","DOI":"10.1158\/1078-0432.CCR-04-2661","volume":"11","author":"S Singhal","year":"2005","unstructured":"Singhal S, et al. Prognostic implications of cell cycle, apoptosis, and angiogenesis biomarkers in non-small cell lung cancer: a review. Clin Cancer Res. 2005;11(11):3974\u201386.","journal-title":"Clin Cancer Res"},{"key":"517_CR21","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.neulet.2015.04.042","volume":"597","author":"D Gorup","year":"2015","unstructured":"Gorup D, et al. Increased expression and colocalization of GAP43 and CASP3 after brain ischemic lesion in mouse. Neurosci Lett. 2015;597:176\u201382.","journal-title":"Neurosci Lett"},{"key":"517_CR22","doi-asserted-by":"publisher","first-page":"529","DOI":"10.3389\/fcell.2020.00529","volume":"8","author":"LL Xiong","year":"2020","unstructured":"Xiong LL, et al. Vi4-miR-185-5p-Igfbp3 network protects the brain from neonatal hypoxic ischemic injury via promoting neuron survival and suppressing the cell apoptosis. Front Cell Dev Biol. 2020;8:529\u201344.","journal-title":"Front Cell Dev Biol"},{"issue":"9","key":"517_CR23","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1002\/jnr.22358","volume":"88","author":"DC Ferrari","year":"2010","unstructured":"Ferrari DC, Nesic OB, Perez-Polo JR. Oxygen resuscitation does not ameliorate neonatal hypoxia\/ischemia-induced cerebral edema. J Neurosci Res. 2010;88(9):2056\u201365.","journal-title":"J Neurosci Res"},{"key":"517_CR24","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3389\/fnins.2019.00016","volume":"13","author":"ZB Zhang","year":"2019","unstructured":"Zhang ZB, et al. miRNA-7a-2-3p inhibits neuronal apoptosis in oxygen-glucose deprivation (OGD) model. Front Neurosci. 2019;13:16.","journal-title":"Front Neurosci"},{"issue":"W1","key":"517_CR25","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1093\/nar\/gky311","volume":"46","author":"M Franz","year":"2018","unstructured":"Franz M, et al. GeneMANIA update 2018. Nucleic Acids Res. 2018;46(W1):60\u20134.","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"517_CR26","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.3109\/10428194.2012.693177","volume":"53","author":"Y Feng","year":"2012","unstructured":"Feng Y, et al. Novel function of scutellarin in inhibiting cell proliferation and inducing cell apoptosis of human Burkitt lymphoma Namalwa cells. Leuk Lymphoma. 2012;53(12):2456\u201364.","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"517_CR27","first-page":"1153","volume":"24","author":"H Li","year":"2010","unstructured":"Li H, et al. Scutellarin inhibits cell migration by regulating production of \u03b1v\u03b26 integrin and E-cadherin in human tongue cancer cells. Oncol Rep. 2010;24(5):1153\u201360.","journal-title":"Oncol Rep"},{"issue":"10","key":"517_CR28","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1002\/ptr.4892","volume":"27","author":"H Xu","year":"2013","unstructured":"Xu H, Zhang S. Scutellarin-induced apoptosis in HepG2 hepatocellular carcinoma cells via a STAT3 pathway. Phytother Res PTR. 2013;27(10):1524\u20138.","journal-title":"Phytother Res PTR"},{"issue":"432623","key":"517_CR29","first-page":"1","volume":"2013","author":"X Chen","year":"2013","unstructured":"Chen X, et al. Scutellarin attenuates hypertension-induced expression of brain Toll-like receptor 4\/nuclear factor kappa B. Mediat Inflamm. 2013;2013(432623):1\u20139.","journal-title":"Mediat Inflamm"},{"issue":"4","key":"517_CR30","first-page":"264","volume":"13","author":"YJ Chen","year":"2015","unstructured":"Chen YJ, et al. Scutellarin attenuates endothelium-dependent aasodilation impairment induced by hypoxia reoxygenation, through regulating the PKG signaling pathway in rat coronary artery. Chin J Nat Med. 2015;13(4):264\u201373.","journal-title":"Chin J Nat Med"},{"issue":"10","key":"517_CR31","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1007\/s12272-014-0541-z","volume":"38","author":"H Tang","year":"2015","unstructured":"Tang H, et al. Investigation on the interactions of scutellarin and scutellarein with bovine serum albumin using spectroscopic and molecular docking techniques. Arch Pharm Res. 2015;38(10):1789\u2013801.","journal-title":"Arch Pharm Res"},{"issue":"6","key":"517_CR32","first-page":"789","volume":"31","author":"LL Guo","year":"2011","unstructured":"Guo LL, Wang YL, Huang Y. Effect of scutellarin on expressions of nicotinic acetylcholine receptor protein and mRNA in the brains of dementia rats. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi Chin J Integr Trad Western Med. 2011;31(6):789\u201393.","journal-title":"Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi Chin J Integr Trad Western Med"},{"issue":"12","key":"517_CR33","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1038\/aps.2011.115","volume":"32","author":"L Guo","year":"2011","unstructured":"Guo L, Guan Z, Wang Y. Scutellarin protects against A\u03b2-induced learning and memory deficits in rats: involvement of nicotinic acetylcholine receptors and cholinesterase. Acta Pharmacol Sin. 2011;32(12):1446\u201353.","journal-title":"Acta Pharmacol Sin"},{"issue":"3","key":"517_CR34","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1083\/jcb.136.3.679","volume":"136","author":"P Caroni","year":"1997","unstructured":"Caroni P, Aigner L, Schneider C. Intrinsic neuronal determinants locally regulate extrasynaptic and synaptic growth at the adult neuromuscular junction. J Cell Biol. 1997;136(3):679\u201392.","journal-title":"J Cell Biol"},{"issue":"1","key":"517_CR35","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1523\/JNEUROSCI.22-01-00239.2002","volume":"22","author":"S Yiping","year":"2002","unstructured":"Yiping S, et al. Growth-associated protein-43 is required for commissural axon guidance in the developing vertebrate nervous system. J Neurosci. 2002;22(1):239\u201347.","journal-title":"J Neurosci"},{"issue":"4765","key":"517_CR36","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1126\/science.3738509","volume":"233","author":"JH Skene","year":"1986","unstructured":"Skene JH, et al. A protein induced during nerve growth (GAP-43) is a major component of growth-cone membranes. Science. 1986;233(4765):783\u20136.","journal-title":"Science"},{"issue":"6","key":"517_CR37","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/S0301-0082(97)00043-9","volume":"53","author":"AB Oestreicher","year":"1997","unstructured":"Oestreicher AB, et al. B-50, the growth associated protein-43: modulation of cell morphology and communication in the nervous system. Prog Neurobiol. 1997;53(6):627\u201386.","journal-title":"Prog Neurobiol"},{"issue":"6","key":"517_CR38","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1523\/JNEUROSCI.3457-15.2016","volume":"36","author":"CC Hung","year":"2016","unstructured":"Hung CC, et al. Astrocytic GAP43 Induced by the TLR4\/NF-\u03baB\/STAT3 Axis Attenuates Astrogliosis-Mediated Microglial Activation and Neurotoxicity. J Neurosci. 2016;36(6):2027\u201343.","journal-title":"J Neurosci"},{"issue":"3","key":"517_CR39","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1523\/JNEUROSCI.09-03-00990.1989","volume":"9","author":"LI Benowitz","year":"1989","unstructured":"Benowitz LI, et al. Localization of the growth-associated phophoprotein GAP-43 (B-50, F1) in the human cerebral cortex. J Neurosci. 1989;9(3):990\u20135.","journal-title":"J Neurosci"},{"issue":"4","key":"517_CR40","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1101\/gr.2161804","volume":"14","author":"JR Walker","year":"2004","unstructured":"Walker JR, et al. Applications of a rat multiple tissue gene expression data set. Genome Res. 2004;14(4):742\u20139.","journal-title":"Genome Res"},{"issue":"1","key":"517_CR41","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.neures.2009.10.002","volume":"66","author":"H Yanagisawa","year":"2010","unstructured":"Yanagisawa H, et al. Pleiotrophin induces neurite outgrowth and up-regulates growth-associated protein (GAP)-43 mRNA through the ALK\/GSK3beta\/beta-catenin signaling in developing mouse neurons. Neurosci Res. 2010;66(1):111\u20136.","journal-title":"Neurosci Res"},{"issue":"3","key":"517_CR42","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1096\/fj.09-140780","volume":"24","author":"F Li","year":"2010","unstructured":"Li F, et al. Pleiotrophin (PTN) is expressed in vascularized human atherosclerotic plaques: IFN-{gamma}\/JAK\/STAT1 signaling is critical for the expression of PTN in macrophages. FASEB J. 2010;24(3):810\u201322.","journal-title":"FASEB J"},{"issue":"21","key":"517_CR43","doi-asserted-by":"publisher","first-page":"4699","DOI":"10.1242\/dev.072157","volume":"138","author":"T Reiff","year":"2011","unstructured":"Reiff T, et al. Midkine and Alk signaling in sympathetic neuron proliferation and neuroblastoma predisposition. Development. 2011;138(21):4699\u2013708.","journal-title":"Development"},{"issue":"1","key":"517_CR44","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1158\/1541-7786.MCR-09-0257","volume":"8","author":"SK Sandur","year":"2010","unstructured":"Sandur SK, et al. 5-hydroxy-2-methyl-1,4-naphthoquinone, a vitamin K3 analogue, suppresses STAT3 activation pathway through induction of protein tyrosine phosphatase, SHP-1: potential role in chemosensitization. Mol Cancer Res. 2010;8(1):107\u201318.","journal-title":"Mol Cancer Res"},{"issue":"6","key":"517_CR45","first-page":"5079","volume":"16","author":"G Wang","year":"2018","unstructured":"Wang G, et al. Crocin promotes apoptosis of human skin cancer cells by inhibiting the JAK\/STAT pathway. Exp Ther Med. 2018;16(6):5079\u201384.","journal-title":"Exp Ther Med"},{"issue":"11","key":"517_CR46","doi-asserted-by":"publisher","first-page":"5327","DOI":"10.1073\/pnas.90.11.5327","volume":"90","author":"SM Strittmatter","year":"1993","unstructured":"Strittmatter SM, et al. GAP-43 augments G protein-coupled receptor transduction in Xenopus laevis oocytes. Proc Natl Acad Sci U S A. 1993;90(11):5327\u201331.","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Chinese Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-021-00517-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13020-021-00517-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-021-00517-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T04:01:54Z","timestamp":1725940914000},"score":1,"resource":{"primary":{"URL":"https:\/\/cmjournal.biomedcentral.com\/articles\/10.1186\/s13020-021-00517-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,18]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["517"],"URL":"https:\/\/doi.org\/10.1186\/s13020-021-00517-z","relation":{},"ISSN":["1749-8546"],"issn-type":[{"value":"1749-8546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,18]]},"assertion":[{"value":"22 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal study was legally approved by the Animal Care & Welfare Committee of Kunming Medical University with the approval number: 2015-1A. All experiments conformed to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"105"}}